OpenVSafe by OpenVAERS
Search V-safe

YT2-11782-59000

4 vaccinations 9 coded responses 38 check-ins 9 free-text entries 4 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
222 / VA
Registered
2021-01-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-25
    Registered in v-safe
  2. 2021-01-25
    Dose 1 — Moderna
  3. 2021-01-25
    Health check-in — day 0, dose 1
    Feeling: Poor · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  4. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Adult check-in
  5. 2021-01-26
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-01-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-01-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  10. 2021-02-01
    Health check-in — day 7, dose 1
    Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-02-08
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-15
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-02-22
    Dose 2 — Moderna
  14. 2021-02-22
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Chills, Headache
    Adult check-in
  15. 2021-02-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  16. 2021-02-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  17. 2021-02-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  18. 2021-03-03
    Survey response — day 7, dose 2
    MedDRA: Asthma, Medical counselling — Feeling: Fair · Nausea · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Systemic reaction (other): Asthma attack after not having one in years. Only recent change has been the vaccine. · Healthcare visit (other): Soufht doctor advice on asthma attack.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-03
    Report sent to call center — day 7, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-03-15
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-24
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-31
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  23. 2021-04-05
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-24
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-06-03
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  26. 2021-06-03
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  27. 2021-08-23
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  28. 2021-12-09
    Dose 3 — Pfizer-BioNTech
  29. 2021-12-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  30. 2021-12-11
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Swollen glands on side of body near shot
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-12-12
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Fair · Fever · Fatigue or tiredness
    Free text: Swollen supraclavicular glands on side of injection
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-12-13
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair
    Free text: Swollen painful glands
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-12-23
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-12-30
    Survey response — day 21, dose 3
    MedDRA: Decreased appetite, Fatigue, Headache, Nausea, Vomiting — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Nasuea, vomiting, headaches, fatigue, loss of appetite
    MedDRA releases: 2024-11 · check-in free text available
  35. 2021-12-30
    Report sent to call center — day 21, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  36. 2022-01-04
  37. 2022-01-10
  38. 2022-01-15
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-01-21
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-03-12
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-06-11
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-09-11
    Dose 4 — Pfizer-BioNTech
  43. 2022-09-11
    Health check-in — day 0, dose 4
    Feeling: Good · None
    Adult check-in
  44. 2022-09-12
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  45. 2022-09-16
    Survey response — days 1–6 daily, dose 4
    MedDRA: Cough, SARS-CoV-2 test positive — Feeling: Poor · Chills, Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Coughing. Tested positive for COVID.
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-09-16
    Report sent to call center — days 1–6 daily, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  47. 2022-09-17
    Survey response — days 1–6 daily, dose 4
    MedDRA: Ageusia, Anosmia, Cough, SARS-CoV-2 test positive — Feeling: Poor · Chills, Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Coughing, loss of taste and smell. Tested positive for COVID
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-09-18
    Survey response — day 7, dose 4
    MedDRA: Ageusia, Anosmia, COVID-19, Cough, Nasopharyngitis — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Cough and cold synotoms, loss of taste and smell due to COVID infection.
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-09-19
  50. 2022-09-19
  51. 2022-10-10
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  52. 2022-10-18
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  53. 2022-10-25
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-25Moderna
22021-02-22Moderna
32021-12-09Pfizer-BioNTech No
42022-09-11Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-01-26 Successful
2021-06-03
Reported to VAERS voluntarily prior to GDIT contact
2021-03-03 Successful
2021-06-03
Reported to VAERS voluntarily prior to GDIT contact
2021-12-30 Unsuccessful
2022-09-16 Unsuccessful

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-28

Systemic reaction (other): Dizziness

Release 5 — day 7, dose 2

2021-03-03

Systemic reaction (other): Asthma attack after not having one in years. Only recent change has been the vaccine.
Healthcare visit (other): Soufht doctor advice on asthma attack.

Release 10 — days 1–6 daily, dose 3

2021-12-11

Systemic reaction (other): Swollen glands on side of body near shot

2021-12-12

Systemic reaction (other): Swollen supraclavicular glands on side of injection

2021-12-13

Systemic reaction (other): Swollen painful glands

Release 10 — day 21, dose 3

2021-12-30

Symptoms: Nasuea, vomiting, headaches, fatigue, loss of appetite

Release 12 — days 1–6 daily, dose 4

2022-09-16

Systemic reaction (other): Coughing. Tested positive for COVID.

2022-09-17

Systemic reaction (other): Coughing, loss of taste and smell. Tested positive for COVID

Release 12 — day 7, dose 4

2022-09-18

Systemic reaction (other): Cough and cold synotoms, loss of taste and smell due to COVID infection.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOAsthma ✓ ✓ ✓
HCVOMedical counselling ✓ ✓ ✓
SDDecreased appetite · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDNausea · · ✓
SDVomiting · · ✓
SROAgeusia · · ✓
SROAnosmia · · ✓
SROAsthma ✓ ✓ ✓
SROCough · · ✓
SROCOVID-19 · · ✓
SRODizziness ✓ ✓ ✓
SROLymph node pain · · ✓
SROLymphadenopathy · · ✓
SRONasopharyngitis · · ✓
SROSARS-CoV-2 test positive · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release